CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 296 filers reported holding CONCENTRIX CORP in Q1 2024. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,141,368 | -27.6% | 17,236 | +7.3% | 0.04% | -35.6% |
| Q4 2023 | $1,576,860 | +40.4% | 16,056 | +14.5% | 0.06% | +15.7% |
| Q3 2023 | $1,123,463 | -42.4% | 14,024 | -41.9% | 0.05% | -41.4% |
| Q2 2023 | $1,949,870 | -14.6% | 24,147 | +28.5% | 0.09% | -24.3% |
| Q1 2023 | $2,284,411 | +52.9% | 18,794 | +67.5% | 0.12% | +9.5% |
| Q4 2022 | $1,493,922 | +83.3% | 11,219 | +53.7% | 0.10% | +59.1% |
| Q3 2022 | $815,000 | -7.6% | 7,297 | +12.2% | 0.07% | -7.0% |
| Q2 2022 | $882,000 | -4.8% | 6,506 | +17.1% | 0.07% | +54.3% |
| Q1 2022 | $926,000 | -14.5% | 5,557 | -8.3% | 0.05% | -11.5% |
| Q4 2021 | $1,083,000 | +372.9% | 6,063 | +368.2% | 0.05% | +160.0% |
| Q3 2021 | $229,000 | -24.7% | 1,295 | -31.6% | 0.02% | -23.1% |
| Q2 2021 | $304,000 | -11.4% | 1,892 | -17.4% | 0.03% | -21.2% |
| Q1 2021 | $343,000 | +51.8% | 2,290 | 0.0% | 0.03% | +37.5% |
| Q4 2020 | $226,000 | – | 2,290 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |